{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:45:53Z","timestamp":1779338753327,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00415-019-09497-5","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T18:02:40Z","timestamp":1566064960000},"page":"2838-2847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Thalassemia and Moyamoya syndrome: unfurling an intriguing association"],"prefix":"10.1007","volume":"266","author":[{"given":"Shambaditya","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souvik","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinal","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhankar","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durjoy","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goutam","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biman Kanti","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-3621","authenticated-orcid":false,"given":"Markus","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,17]]},"reference":[{"key":"9497_CR1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226\u20131237","journal-title":"N Engl J Med"},{"key":"9497_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2176\/nmc.ra.2014-0307","volume":"55","author":"M Fujimura","year":"2015","unstructured":"Fujimura M, Tominaga T (2015) Diagnosis of moyamoya disease: international standard and regional differences. Neurol Med Chir (Tokyo) 55:189\u2013193","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"9497_CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s13760-017-0844-1","volume":"118","author":"M Zhao","year":"2018","unstructured":"Zhao M, Zhang D, Wang S, Zhang Y, Wang R, Deng X et al (2018) Posterior circulation involvement in pediatric and adult patients with moyamoya disease: a single center experience in 574 patients. Acta Neurol Belg 118:227\u2013233","journal-title":"Acta Neurol Belg"},{"key":"9497_CR4","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood.V99.9.3144","volume":"99","author":"SR Dobson","year":"2002","unstructured":"Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D et al (2002) Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 99:3144\u20133150","journal-title":"Blood"},{"key":"9497_CR5","first-page":"710","volume":"43","author":"A Mukherjee","year":"1995","unstructured":"Mukherjee A (1995) Moyamoya disease and beta-thalassemia. J Assoc Physicians India 43:710\u2013711","journal-title":"J Assoc Physicians India"},{"key":"9497_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/08830738060210010501","volume":"21","author":"M Sanefuji","year":"2006","unstructured":"Sanefuji M, Ohga S, Kira R, Yoshiura T, Torisu H, Hara T (2006) Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia. J Child Neurol 21:75\u201377","journal-title":"J Child Neurol"},{"key":"9497_CR7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pediatrneurol.2007.09.011","volume":"38","author":"FA Marden","year":"2008","unstructured":"Marden FA, Putman CM, Grant JM, Greenberg J (2008) Moyamoya disease associated with hemoglobin Fairfax and beta-thalassemia. Pediatr Neurol 38:130\u2013132","journal-title":"Pediatr Neurol"},{"key":"9497_CR8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pbc.21850","volume":"52","author":"TM Parker","year":"2009","unstructured":"Parker TM, Ward LM, Johnston DL, Ventureya E, Klaassen RJ (2009) A case of Moyamoya syndrome and hemoglobin E\/beta-thalassemia. Pediatr Blood Cancer 52:422\u2013424","journal-title":"Pediatr Blood Cancer"},{"key":"9497_CR9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jocn.2009.10.023","volume":"17","author":"BK G\u00f6ksel","year":"2010","unstructured":"G\u00f6ksel BK, Ozdogu H, Yildirim T, O\u011fuzkurt L, Asma S (2010) Beta-thalassemia intermedia associated with moyamoya syndrome. J Clin Neurosci 17:919\u2013920","journal-title":"J Clin Neurosci"},{"key":"9497_CR10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MPH.0b013e3181ed0e84","volume":"32","author":"S Oberoi","year":"2010","unstructured":"Oberoi S, Bansal D, Singh P, Marwaha RK (2010) Stroke in a young boy with \u03b2-thalassemia intermedia secondary to moyamoya syndrome. J Pediatr Hematol Oncol 32:568\u2013570","journal-title":"J Pediatr Hematol Oncol"},{"key":"9497_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/08880018.2011.583976","volume":"28","author":"A Ray","year":"2011","unstructured":"Ray A, Rodriguez N (2011) Cerebral infarction in the setting of moyamoya in a pediatric patient with sickle \u03b2+-thalassemia. Pediatr Hematol Oncol 28:535\u2013537","journal-title":"Pediatr Hematol Oncol"},{"key":"9497_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bcmd.2013.05.005","volume":"51","author":"A Inati","year":"2013","unstructured":"Inati A, Tourjuman O, Bizri D, Dhayni R, Abbas HA, Tfaili H et al (2013) A rare case of Moyamoya syndrome in a \u03b2-thalassemia major patient. Blood Cells Mol Dis 51:149\u2013150","journal-title":"Blood Cells Mol Dis"},{"issue":"1C","key":"9497_CR13","first-page":"345","volume":"2","author":"J Nadkarni","year":"2014","unstructured":"Nadkarni J, Pal P, Dwivedi R, Singh A (2014) Vasculopathy in beta thalassemia intermedia: a rare case report. Sch J App Med Sci 2(1C):345\u2013347","journal-title":"Sch J App Med Sci"},{"key":"9497_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15274\/NRJ-2014-10003","volume":"27","author":"AH El Beltagi","year":"2014","unstructured":"El Beltagi AH, El-Sheikh A, El-Saif R, Norbash A (2014) Ivy sign in mildly symptomatic \u03b2-thalassemia intermedia, with development of moyamoya disease. Neuroradiol J 27:23\u201328","journal-title":"Neuroradiol J"},{"key":"9497_CR15","first-page":"113","volume":"15","author":"KN Sarkar","year":"2016","unstructured":"Sarkar KN, Deoghuria D, Sarkar M, Sarkar S (2016) Moyamoya syndrome in a HbE beta thalassemic child presenting with hemiplegia in rural West Bengal. IOSR J Med Dent Sci 15:113\u2013118","journal-title":"IOSR J Med Dent Sci"},{"key":"9497_CR16","doi-asserted-by":"publisher","DOI":"10.21304\/2017.0403.00208","author":"A Gupta","year":"2017","unstructured":"Gupta A, Mathur P, Sharma M, Parmar V (2017) A rare case of compound heterozygous B-thalassemia and hereditary persistence of fetal hemoglobin with Moya-Moya disease. J Pediatr Crit Care. \n                    https:\/\/doi.org\/10.21304\/2017.0403.00208","journal-title":"J Pediatr Crit Care"},{"key":"9497_CR17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/jpgm.JPGM_468_17","volume":"64","author":"PN Doctor","year":"2018","unstructured":"Doctor PN, Choudhari A, Verma M, Merchant RH (2018) Moyamoya syndrome in hemoglobin E-beta thalassemia: A rare presentation and association. J Postgrad Med 64:240\u2013242","journal-title":"J Postgrad Med"},{"key":"9497_CR18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.mph.0000175409.21342.ea","volume":"27","author":"K Brockmann","year":"2005","unstructured":"Brockmann K, Stolpe S, Fels C, Khan N, Kulozik AE, Pekrun A (2005) Moyamoya syndrome associated with hemolytic anemia due to Hb Alesha. J Pediatr Hematol Oncol 27:436\u2013440","journal-title":"J Pediatr Hematol Oncol"},{"key":"9497_CR19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000381331","volume":"5","author":"A Haque","year":"2015","unstructured":"Haque A, Quint DJ, Castle VP, Leber SM (2015) Another rare unstable hemoglobinopathy: hemoglobin Casper\/Southampton associated with Moyamoya disease. Cerebrovasc Dis Extra 5:52\u201354","journal-title":"Cerebrovasc Dis Extra"},{"key":"9497_CR20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fneur.2017.00425","volume":"8","author":"JG Shulman","year":"2017","unstructured":"Shulman JG, Snider S, Vaitkevicius H, Babikian VL, Patel NJ (2017) Direct visualization of arterial emboli in Moyamoya syndrome. Front Neurol 8:425","journal-title":"Front Neurol"},{"key":"9497_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1331.2011.03481.x","volume":"19","author":"M Kraemer","year":"2012","unstructured":"Kraemer M, Berlit P, Diesner F, Khan N (2012) What is the expert\u2019s option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey. Eur J Neurol 19:163\u2013167","journal-title":"Eur J Neurol"},{"key":"9497_CR22","first-page":"423","volume":"10","author":"M Franchini","year":"2012","unstructured":"Franchini M, Manucci PM (2012) Hypercoagulability in congenital haemolyticanaemias. Blood Transfus 10:423\u2013427","journal-title":"Blood Transfus"},{"key":"9497_CR23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/ehm.12.42","volume":"5","author":"MD Cappellini","year":"2012","unstructured":"Cappellini MD, Poggiali E, Taher AT, Musallam KM (2012) Hypercoagulability in \u03b2-thalassemia: a status quo. Expert Rev Hematol 5:505\u2013511","journal-title":"Expert Rev Hematol"},{"issue":"Suppl 1","key":"9497_CR24","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0268-960X(12)70007-3","volume":"26","author":"MD Cappellini","year":"2012","unstructured":"Cappellini MD, Musallam KM, Poggiali E, Taher AT (2012) Hypercoagulability in non-transfusion-dependent thalassemia. Blood Rev 26(Suppl 1):S20\u2013S23","journal-title":"Blood Rev"},{"key":"9497_CR25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.blre.2008.04.001","volume":"22","author":"AT Taher","year":"2008","unstructured":"Taher AT, Otrock ZK, Uthman I, Cappellini MD (2008) Thalassemia and hypercoagulability. Blood Rev 22:283\u2013292","journal-title":"Blood Rev"},{"key":"9497_CR26","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1538-7836.2010.03940.x","volume":"8","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S et al (2010) Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost 8:2152\u20132158","journal-title":"J Thromb Haemost"},{"key":"9497_CR27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V99.1.36","volume":"99","author":"A Eldor","year":"2002","unstructured":"Eldor A, Rachmilewitz EA (2002) The hypercoagulable state in thalassemia. Blood 99:36\u201343","journal-title":"Blood"},{"key":"9497_CR28","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","volume":"115","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S et al (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 115:1886\u20131892","journal-title":"Blood"},{"key":"9497_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830440114","volume":"44","author":"V Borenstain-Ben Yashar","year":"1993","unstructured":"Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A (1993) Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 44:63\u201365","journal-title":"Am J Hematol"},{"key":"9497_CR30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2141.1997.1502965.x","volume":"98","author":"A Ruf","year":"1997","unstructured":"Ruf A, Pick M, Deutsch V, Patscheke H, Goldfarb A, Rachmilewitz EA et al (1997) In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol 98:51\u201356","journal-title":"Br J Haematol"},{"key":"9497_CR31","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1538-7836.2010.04030.x","volume":"8","author":"PM Mannucci","year":"2010","unstructured":"Mannucci PM (2010) Red cells playing as activated platelets in thalassemia intermedia. J Thromb Haemost 8:2149\u20132151","journal-title":"J Thromb Haemost"},{"key":"9497_CR32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2141.2000.02376.x","volume":"111","author":"MD Cappellini","year":"2000","unstructured":"Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP (2000) Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 111:467\u2013473","journal-title":"Br J Haematol"},{"key":"9497_CR33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1160\/TH08-03-0157","volume":"100","author":"N Goldschmidt","year":"2008","unstructured":"Goldschmidt N, Spectre G, Brill A, Zelig O, Goldfarb A, Rachmilewitz E et al (2008) Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells. Thromb Haemost 100:864\u2013870","journal-title":"Thromb Haemost"},{"key":"9497_CR34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.1993.tb03033.x","volume":"84","author":"D Del Principe","year":"1993","unstructured":"Del Principe D, Menichelli A, Di Giulio S, De Matteis W, Cianciulli P, Papa G (1993) PADGEM\/GMP-140 expression on platelet membranes from homozygous beta thalassaemic patients. Br J Haematol 84:111\u2013117","journal-title":"Br J Haematol"},{"key":"9497_CR35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.thromres.2007.02.006","volume":"120","author":"A Tripatara","year":"2007","unstructured":"Tripatara A, Jetsrisuparb A, Teeratakulpisarn J, Kuaha K (2007) Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia\/hemoglobin E disease. Thromb Res 120:805\u2013810","journal-title":"Thromb Res"},{"key":"9497_CR36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.15537\/smj.2015.2.9978","volume":"36","author":"ZM Al-Hawsawi","year":"2015","unstructured":"Al-Hawsawi ZM, Al-Zaid MA, Barnawi AI, Yassine SM (2015) Fanconi anemia associated with moyamoya disease in Saudi Arabia. Saudi Med J 36:233\u2013235","journal-title":"Saudi Med J"},{"key":"9497_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MPH.0000000000000789","volume":"39","author":"E Gait-Carr","year":"2017","unstructured":"Gait-Carr E, Connolly DJ, King D (2017) Moyamoya syndrome associated with hereditary spherocytosis: an emerging clinical entity. J Pediatr Hematol Oncol 39:233\u2013234","journal-title":"J Pediatr Hematol Oncol"},{"key":"9497_CR38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/08880018.2011.650838","volume":"29","author":"SS Meena","year":"2012","unstructured":"Meena SS, Ramkumar TV, Sharma S, Aneja S, Kumar A (2012) Moyamoya syndrome associated with severe iron deficiency anemia in a young child. Pediatr Hematol Oncol 29:368\u2013371","journal-title":"Pediatr Hematol Oncol"},{"key":"9497_CR39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/08830738030180111301","volume":"18","author":"MW Butrum","year":"2003","unstructured":"Butrum MW, Williams LS, Golomb MR (2003) A child with Diamond-Blackfan anemia, methylenetetrahydrofolate reductase mutation, and perinatal stroke. J Child Neurol 18:800\u2013802","journal-title":"J Child Neurol"},{"key":"9497_CR40","first-page":"2874","volume":"131","author":"ZJ Cheng","year":"2018","unstructured":"Cheng ZJ, Shen YY, Warsame IM, Dai TM, Tu JL (2018) Moyamoya syndrome caused by paroxysmal nocturnal hemoglobinuria. Chin Med J (Engl) 131:2874\u20132876","journal-title":"Chin Med J (Engl)"},{"key":"9497_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000442298","volume":"41","author":"A Bersano","year":"2016","unstructured":"Bersano A, Guey S, Bedini G, Nava S, Herv\u00e9 D, Vajkoczy P, European Moyamoya Disease Initiative et al (2016) Research progresses in understanding the pathophysiology of Moyamoya disease. Cerebrovasc Dis 41:105\u2013118","journal-title":"Cerebrovasc Dis"},{"key":"9497_CR42","doi-asserted-by":"crossref","first-page":"e0200446","DOI":"10.1371\/journal.pone.0200446","volume":"13","author":"C Santoro","year":"2018","unstructured":"Santoro C, Giugliano T, Kraemer M, Torella A, Schwitalla JC, Cirillo M et al (2018) Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1. PLoS ONE 13:e0200446","journal-title":"PLoS ONE"},{"key":"9497_CR43","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/STROKEAHA.118.023972","volume":"50","author":"L Grangeon","year":"2019","unstructured":"Grangeon L, Guey S, Schwitalla JC, Bergametti F, Arnould M, Corpechot M (2019) Clinical and molecular features of five European multigenerational families with Moyamoya angiopathy. Stroke 50:789\u2013796","journal-title":"Stroke"},{"key":"9497_CR44","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.22195","volume":"224","author":"I Akinsheye","year":"2010","unstructured":"Akinsheye I, Klings ES (2010) Sickle cell anemia and vascular dysfunction: the nitric oxide connection. J Cell Physiol 224:620\u2013625","journal-title":"J Cell Physiol"},{"key":"9497_CR45","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1440-1681.2007.04639.x","volume":"34","author":"KC Wood","year":"2007","unstructured":"Wood KC, Granger DN (2007) Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clin Exp Pharmacol Physiol 34:926\u2013932","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9497_CR46","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/ars.2016.6806","volume":"26","author":"RE Hirsch","year":"2017","unstructured":"Hirsch RE, Sibmooh N, Fucharoen S, Friedman JM (2017) HbE\/\u03b2-thalassemia and oxidative stress: the key to pathophysiological mechanisms and novel therapeutics. Antioxid Redox Signal 26:794\u2013813","journal-title":"Antioxid Redox Signal"},{"key":"9497_CR47","doi-asserted-by":"crossref","first-page":"e0203955","DOI":"10.1371\/journal.pone.0203955","volume":"13","author":"A Chamchoi","year":"2018","unstructured":"Chamchoi A, Srihirun S, Paiboonsukwong K, Sriwantana T, Sathavorasmith P, Pattanapanyasat K et al (2018) Decreased nitrite reductase activity of deoxyhemoglobin correlates with platelet activation in hemoglobin E\/\u00df-thalassemia subjects. PLoS ONE 13:e0203955","journal-title":"PLoS ONE"},{"key":"9497_CR48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajhg.2014.01.018","volume":"94","author":"D Herv\u00e9","year":"2014","unstructured":"Herv\u00e9 D, Philippi A, Belbouab R, Zerah M, Chabrier S, Collardeau-Frachon S et al (2014) Loss of \u03b11\u03b21 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia. Am J Hum Genet 94:385\u2013394","journal-title":"Am J Hum Genet"},{"key":"9497_CR49","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","volume":"114","author":"SE Crary","year":"2009","unstructured":"Crary SE, Buchanan GR (2009) Vascular complications after splenectomy for hematologic disorders. Blood 114:2861\u20132868","journal-title":"Blood"},{"key":"9497_CR50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3324\/haematol.13610","volume":"94","author":"B Bader-Meunier","year":"2009","unstructured":"Bader-Meunier B, Verlhac S, Elmaleh-Berg\u00e8s M, Ithier G, Sellami F, Faid S et al (2009) Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia. Haematologica 94:123\u2013126","journal-title":"Haematologica"},{"key":"9497_CR51","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1182\/blood.V126.23.2071.2071","volume":"126","author":"AM Schlenz","year":"2015","unstructured":"Schlenz AM, Antonucci MU, Cafiero R, Burkett NS, Kanter J (2015) Moyamoya disease predicts progression of cerebral vasculopathy in patients with sickle cell disease despite chronic transfusion therapy. Blood 126:2071","journal-title":"Blood"},{"key":"9497_CR52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim JS (2016) Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke 18:2\u201311","journal-title":"J Stroke"},{"key":"9497_CR53","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3174\/ajnr.A5700","volume":"39","author":"T Matsushige","year":"2018","unstructured":"Matsushige T, Kraemer M, Sato T, Berlit P, Forsting M, Ladd ME et al (2018) Visualization and classification of deeply seated collateral networks in Moyamoya angiopathy with 7T MRI. Am J Neuroradiol 39:1248\u20131254","journal-title":"Am J Neuroradiol"},{"key":"9497_CR54","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00415-018-9031-4","volume":"265","author":"M Kraemer","year":"2018","unstructured":"Kraemer M, Karakaya R, Matsushige T, Graf J, Albrecht P, Hartung HP et al (2018) Efficacy of STA-MCA bypass surgery in moyamoya angiopathy: long-term follow-up of the Caucasian Krupp Hospital cohort with 81 procedures. J Neurol 265:2425\u20132433","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09497-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T23:40:45Z","timestamp":1597534845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09497-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,17]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9497"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09497-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,17]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All patients gave their permission for publication. They underwent no study-specific procedures, so no permission from the ethical committee was necessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}